INDUSTRY-ACADEMIC-CLINICAL FORUM

Size: px

Start display at page:

Download "INDUSTRY-ACADEMIC-CLINICAL FORUM"

Gregory Bradley
8 years ago
Views:

1 INDUSTRY-ACADEMIC-CLINICAL FORUM FUTURE TRENDS IN NANOMEDICINE FOR DIAGNOSTICS AND THERAPY IN ONCOLOGY Parc Científic de Barcelona / Barcelona Science Park 25 th of October of 2012 TABLE OF CONTENTS Agenda 2 Practical Aspects 3 Order of Presentations 4 5 Plan of Rooms and Tables for Meetings (Partnering) 6 Page Page 1 of 6

th of October of 2012 TABLE OF CONTENTS Agenda 2 Practical Aspects 3 Order of

2 AGENDA Date: 25 th of October of 2012 Place: Barcelona Science Park - Towers R+D+I Auditorium in Hall Tower D (ground floor) 4, Baldiri Reixach street Barcelona Registration Welcome Dr. Jesús Purroy, Scientific Director, PCB Mr. Carlos Lurigados, Project Director, Biocat Practical issues for the development of the forum Dr. Fernando Santos, Technology Transfer Manager, CIBER-BBN Research Groups flash presentations (5 minutes each) Please, see order of presentations in page Coffee break Clinical Groups and Companies flash presentations (5 minutes each). Please, see order of presentations in page Closing remarks Dr. Pablo Laguna, Scientific Director, CIBER-BBN Lunch One-to-one meetings (15 minutes each) Page 2 of 6

Fernando Santos, Technology Transfer Manager, CIBER-BBN 9.10-11.10 Research Groups flash presentations (5 minutes each) Please, see order of presentations in page 4 11.10-11.30 Coffee break 11.30-13.

3 PRACTICAL ASPECTS 1) Flash Presentations: a. English will be used for presentations. b. We kindly request to comply to 5 minutes presentations. c. No time for questions will exists between the different presentations. Further information will be provided at one-to-one meetings (partnering). 2) Partnering Meetings: a. Use the partnering tool to request and accept meetings. Register / Log-in: b. Partnering meetings will have duration of 15 minutes. Punctuality and adjustment to the meeting schedule will be requested. c. The time should be sufficient to identify important mutual interests and to organize future meetings. The partners are encouraged to set-up another date for deeper discussion, if necessary. 3) Wi-Fi: At Barcelona Science Park, on 25 th of October. User: ciber-guest Password: UARS7CXv 4) Questions to: fsantos@ciber-bbn.es Fernando Santos Technology Transfer Manager, CIBER-BBN Page 3 of 6

plataformatecnologiasanitaria.es/partnering_evento.php?i=7 b. Partnering meetings will have duration of 15 minutes. Punctuality and adjustment to the meeting schedule will be requested. c.

4 Research Groups Flash Presentations (5 min. each) 1 Anticancer Therapy Group, Dr. Carles J. Ciudad University of Barcelona, 2 Centre of Research in Toxicology (Ceretox) Dr. Miquel Borrás 3 Small System and Biomolecule Physics Group (BIOSMALL-UB) Dr. Félix Ritort University of Barcelona, CIBER-BBN, 4 Nanobiosensors and Bioanalytical Applications (CIN2-CSIC) Dr. Laura Lechuga Spanish National Research Council (CSIC), CIBER-BBN, 5 Drug Delivery and Targeting Group (GDLF-HUVH) Dr. Ibane Abásolo University Hospital Vall d Hebron, CIBER-BBN, 6 Applied Microbiology Research Group (IBB-UAB) Dr. Esther Vázquez Biotechnology and Biomedicine Institute (UAB) CIBER-BBN, 7 Oncogenesis and Antitumor Group (GOA-HSCSP) Dr. Ramón Mangues Research Inst., Hospital de la Santa Cruz y San Pablo, CIBER-BBN, 8 Nucleic Acid Chemistry Group (GQNA-CSIC) Dr. Ramón Eritja Institute for Advanced Chemistry of Catalonia (CSIC), CIBER-BBN, 9 Nanoparticle and Peptide Chemical Group (IRB) Dr. Miriam Royo Biomedicine Research Institute, CIBER-BBN, 10 Nanomedicine Group (NANOMED-IBEC) Dr. Josep Samitier Bioengineering Institute of Catalonia (IBEC), CIBER-BBN, 11 Molecular Nanoscience and Organic Materials Group (NANOMOL-CSIC) Dr. Santiago Sala Materials Science Institute of Barcelona (CSIC), CIBER-BBN, 12 Nanobiotechnology for Diagnostics (NB4D-IQAC) Dr. Pilar Marco Institute for Advanced Chemistry of Catalonia (CSIC), CIBER-BBN, 13 Structural Mechanics and Material Modeling Group (GEMM-I3A) Dr. Luis J. Fernández Engineering Research Inst. of Aragón (U. of Zaragoza), CIBER-BBN, Zaragoza, Spain 14 Multifunctional Molecular Magnetic Materials Group (M4-CSIC) Dr. Fernando Palacio Materials Science Institute of Aragón (CSIC), CIBER-BBN, Zaragoza, Spain 15 Bioengineering and Telemedicine Group (GBT-UPM) Dr. José Javier Serrano Universidad Politécnica de Madrid, CIBER-BBN, Madrid, Spain 16 Molecular Immunobiology Laboratory (LIBM-HGUGM) Dr. M. Ángeles Muñoz University Hospital Gregorio Marañón, CIBER-BBN, Madrid, Spain 17 Dendrimer Group for Biomedical Applications (GDAB-UAH) Dr. Rafael Gómez University of Alcalá de Henares, CIBER-BBN, Alcalá de Henares (Madrid) Spain 18 Applied Molecular Chemistry Group (IQMA-UPV) Dr. Ramón Martínez Applied Mol. Chem. Inst. (U. Politécnica de Valencia), CIBER-BBN, Valencia, Spain 19 Group for Advanced Materials and Nanobiotechnology (BIOFORGE-UVA) Dr. Alessandra Girotti University of Valladolid, CIBER-BBN, Valladolid, Spain 20 CIBER-BBN Research Services Dr. Jesús M. Izco Zaragoza, Spain 21 Neuroprosthesis and Neuroengineering Research Group (NN-UMH) Dr. Eduardo Fernández University Miguel Hernández, CIBER-BBN, Elche (Alicante), Spain Page 4 of 6

Laura Lechuga Spanish National Research Council (CSIC), CIBER-BBN, 5 Drug Delivery and Targeting Group (GDLF-HUVH) Dr.

5 Clinical Groups and Companies Flash Presentations (5 min. each) 1 Laboratory Research Cancer Group / Oncology Pathology Research Group Dr. Xavier Matias-Guiu IRB Lleida, Hospital Arnau de Vilanova, Lleida, Spain 2 Diagnosis and therapy in oncology Dr. David Fuster IDIBAPS (Hospital Clinic) 3 Biological Markers in Oncology Dr. Rafael Molina IDIBAPS (Hospital Clinic) 4 Colorectal Cancer Group Dr. Victor Moreno IDIBELL (Hospital de Bellvitge), 5 Breast Cancer Group Dr. Ander Urruticoechea IDIBELL (Hospital de Bellvitge), 6 Sarcoma Research Group Dr. Óscar Martínez-Tirado IDIBELL (Hospital de Bellvitge), 7 Research Unit in Biomedicine and Translational and Pediatrics Oncology Dr. Jaume Reventós Research Institute, Vall d'hebron University Hospital, 8 Transbiomed Dr. Marcelo Viegas 9 VCN Biosciences Dr. Manel Cascalló L Hospitalet de Llobregat (Barcelona) Spain 10 Advanced Marker Discovery (AMADIX) Dr. Ana Martín Madrid, Spain 11 TCD Pharma Dr. Nicholas Occleston Valladolid, Spain 12 Apointech Dr. Emmanuel Fajardo Villamayor (Salamanca), Spain 13 Argon Pharma Dr. Óscar Peña 14 BCN Peptides. Dr. Lluis Riera Sant Quintí de Mediona (Barcelona) Spain 15 Endor Nanotechnologies Dr. Luciano Sobrevals 16 Ferrer Group Dr. Andrés G. Fernández 17 Gendiag Dr. Eduardo Salas 18 Lykera Biomed Dr. Francesc Mitjans 19 NTE-Sener Dr. Josep M. Escuer Cerdanyola del Vallès (Barcelona) Spain 20 Vivia Biotech Dr. Resu Alloza Tres Cantos (Madrid) Spain Page 5 of 6

Rafael Molina IDIBAPS (Hospital Clinic) 4 Colorectal Cancer Group Dr. Victor Moreno IDIBELL (Hospital de Bellvitge), 5 Breast Cancer Group Dr.

6 PLAN OF ROOMS AND TABLES FOR MEETINGS (PARTNERING) AUDITORIUM Morning: Presentations Afernoon: PARTNERING Tables Tower D Ground floor Tower I Ground floor Elevators to 3 rd floor Tower I Room 4 UNavailable Room 3 Tables 2-3 Room 2 Table 1 Room 1 UNavailable Tower I 3 rd floor Elevators Room 4 Room 3 Room 2 Room 1 Tables Table 11 Tables 9-10 Tables 4-8 Page 6 of 6

Tower I Room 4 UNavailable Room 3 Tables 2-3 Room 2 Table 1 Room 1 UNavailable Tower I 3 rd

The Catalan nanobiomedicine alliance

The Catalan nanobiomedicine alliance BioNanoMed Catalunya BioNanoMed Catalunya The Catalan nanobiomedicine alliance Nanobiomedicine is one of the strong points of research in Catalonia (Biocat Report 2009*).